Cargando…

Could Adjuvant Chemotherapy Improve Prognosis for Cervical Cancer Patients with Elevated Pretreatment Serum Squamous-Cell Carcinoma Antigen?

OBJECTIVE: The aim of this study was to explore whether adjuvant chemotherapy could improve prognosis for cervical cancer patients with elevated pretreatment serum squamous-cell carcinoma antigen (SCC-Ag). METHODS: Propensity-score matching and inverse probability of treatment weighting (IPTW) were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Zhen, Cao, Dongyan, Zhang, Ying, Shen, Keng, Yang, Jiaxin, Yu, Mei, Zhou, Huimei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810669/ https://www.ncbi.nlm.nih.gov/pubmed/33469394 http://dx.doi.org/10.2147/RMHP.S273848

Ejemplares similares

Importance of Standard Treatment in Prognosis of Patients with Ovarian Cancer and Associated Cerebral Infarction
por: Yuan, Zhen, et al.
Publicado: (2020)

Laparoscopic vs. Open Abdominal Radical Hysterectomy for Cervical Cancer: A Single-Institution, Propensity Score Matching Study in China
por: Yuan, Zhen, et al.
Publicado: (2019)

Evaluating the Guiding Role of Elevated Pretreatment Serum Carcinoembryonic Antigen Levels for Adjuvant Chemotherapy in Stage IIA Colon Cancer: A Large Population-Based and Propensity Score-Matched Study
por: Liu, Qi, et al.
Publicado: (2019)

Analysis of treatment modalities and prognosis on microinvasive cervical cancer: a 10-year cohort study in China
por: Qian, Qiuhong, et al.
Publicado: (2014)

Clinical utility of pretreatment serum squamous cell carcinoma antigen for prognostication and decision-making in patients with early-stage cervical cancer
por: Huang, Xiao-Dan, et al.
Publicado: (2023)

Neoadjuvant chemotherapy in locally advanced cervical carcinoma: which is better, intravenous or intra-arterial?
por: Gui, Ting, et al.
Publicado: (2014)

Can Elevated Pretreatment Serum Carcinoembryonic Antigen Levels Serve as a Potential Biomarker Guiding Adjuvant Chemotherapy in Rectal Cancer Patients With ypTis-3N0 After Neoadjuvant Radiotherapy and Surgery?
por: Huang, Chi, et al.
Publicado: (2021)

Pretreatment tumour-antigen Ta-4 in serum of patients with squamous cell carcinoma of the uterine cervix.
por: Kenter, G., et al.
Publicado: (1987)

Evaluation of Cervical High-Grade Squamous Intraepithelial Lesions-Correlated Markers as Triage Strategy for Colposcopy After Co-Testing
por: Huo, Xiao, et al.
Publicado: (2021)

Corrigendum: Uterine Adenosarcoma: A Retrospective 12-Year Single-Center Study
por: Yuan, Zhen, et al.
Publicado: (2019)

Uterine Adenosarcoma: A Retrospective 12-Year Single-Center Study
por: Yuan, Zhen, et al.
Publicado: (2019)

Impact of Adjuvant Chemotherapy on FIGO Stage I Ovarian Clear Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Yin, Min, et al.
Publicado: (2022)

Extrafascial hysterectomy after concurrent chemoradiotherapy in locally advanced cervical adenocarcinoma
por: Yang, Jie, et al.
Publicado: (2016)

High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy
por: Zhou, Wenhao, et al.
Publicado: (2019)

Postoperative Adjuvant Chemotherapy Improved the Prognosis in Locally Advanced Cervical Cancer Patients With Optimal Response to Neoadjuvant Chemotherapy
por: Feng, Xiaojie, et al.
Publicado: (2020)

Clinical Features and Prognostic Factors of Cervical Clear Cell Adenocarcinoma: A Retrospective Analysis of 74 Cases from a Tertiary Hospital
por: Liu, Yue, et al.
Publicado: (2023)

A novel prognostic model: which group of esophageal squamous cell carcinoma patients could benefit from adjuvant chemotherapy
por: Zhou, Zihao, et al.
Publicado: (2022)

Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma
por: Chen, Peng, et al.
Publicado: (2020)

Evaluation of Chemotherapy Response with Serum Squamous Cell Carcinoma Antigen Level in Cervical Cancer Patients: A Prospective Cohort Study
por: Yin, Mingzhu, et al.
Publicado: (2013)

The Non-Cancer Specific Elevation of the Serum Squamous Cell Carcinoma Antigen during the Post-Radiotherapy Follow-Up of Cervical Cancer Patients
por: Oike, Tae, et al.
Publicado: (2021)

Pretreatment Squamous Cell Carcinoma Antigen (SCC-Ag) as a Predictive Factor for the Use of Consolidation Chemotherapy in Cervical Cancer Patients After Postoperative Extended-Field Concurrent Chemoradiotherapy
por: Zhang, Guangyu, et al.
Publicado: (2021)

Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma
por: Wang, Jun-Ye, et al.
Publicado: (2012)

Adjuvant chemotherapy for early-stage cervical cancer
por: Asano, Hiroshi, et al.
Publicado: (2016)

Neoadjuvant chemotherapy followed by fertility-sparing surgery for women with stage IB1 cervical cancer
por: Wang, Dan, et al.
Publicado: (2013)

Is adjuvant chemotherapy beneficial for patients with FIGO stage IC adult granulosa cell tumor of the ovary?
por: Wang, Dan, et al.
Publicado: (2018)

Tumor Volume Predicts High-Risk Patients and Guides Initial Chemoradiotherapy for Early Cervical Cancer
por: Zhang, Jingjing, et al.
Publicado: (2021)

Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer
por: Li, Jing, et al.
Publicado: (2016)

Could Adjuvant Chemotherapy after Surgery Benefit Elderly Patients with Advanced Gastric Cancer?
por: Jeong, Jin Woon, et al.
Publicado: (2016)

Who could complete and benefit from the adjuvant chemotherapy regarding pancreatic ductal adenocarcinoma? A multivariate‐adjusted analysis at the pre‐adjuvant chemotherapy timing
por: Fu, Ningzhen, et al.
Publicado: (2022)

Pretreatment Serum Uric Acid as an Efficient Predictor of Prognosis in Men with Laryngeal Squamous Cell Cancer: A Retrospective Cohort Study
por: Hsueh, Chi-Yao, et al.
Publicado: (2019)

Completion hysterectomy after chemoradiotherapy for locally advanced adeno-type cervical carcinoma: updated survival outcomes and experience in post radiation surgery
por: Yang, Jie, et al.
Publicado: (2019)

The prognostic value of pretreatment CA-125 levels and CA-125 normalization in ovarian clear cell carcinoma: a two-academic-institute study
por: Bai, Huimin, et al.
Publicado: (2016)

Identification of prognosis markers for endometrial cancer by integrated analysis of DNA methylation and RNA-Seq data
por: Huo, Xiao, et al.
Publicado: (2019)

Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer
por: Markovina, Stephanie, et al.
Publicado: (2018)

Progress in immunocytochemical staining for cervical cancer screening
por: Sun, Hengzi, et al.
Publicado: (2019)

The Role of Adjuvant Chemotherapy in the Treatment of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemotherapy
por: Li, Keting, et al.
Publicado: (2023)

Predictive value of microvessel features for the clinical response to neoadjuvant chemotherapy in cervical squamous carcinoma and the associations with prognosis
por: Li, Weili, et al.
Publicado: (2021)

Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors
por: Guo, Hong-tao, et al.
Publicado: (2020)

Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer
por: Chen, Dexin, et al.
Publicado: (2021)

Lumpectomy Combined with Adjuvant Radiotherapy Could Be a Treatment Option for Primary Squamous Cell Carcinoma of the Breast
por: Qi, Wei Xiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t3v1qkf76s5av945ec2fkfbar8